Prevalence and Risk factors of Hospital Readmission for Phototherapy due to Rebound Neonatal Jaundice in Chaiyaphum hospital

Authors

  • Sutatip Watthanaphanalai Department of Pediatrics, Chaiyaphum hospital

Keywords:

rebound neonatal jaundice, phototherapy, prevalence, risk factor

Abstract

Background : Neonatal jaundice is a common causes of hospitalization in neonates.Jaundice in neonate require timely treatment for preventing kernicterus.
Objective : To analyze the prevalence and risk factor for readmission for Phototherapy due to Rebound Neonatal Jaundice in Chaiyaphum hospital.
Method : We conducted a retrospective cohort study of infants with jaundice gestational age(GA) ≥35 weeks and and aged 14 days in Chaiyaphum hospital from 1st June 2019 ถึง 31st May 2020.
Result : There were 338 infants with GA≥35 weeksreceiving phototherapy before hospital discharge, 54 (15.98%) of them were readmitted for phototherapy due to rebound jaundice. Readmitted infants had a mean birth weight and gestational age of 2790 ± 502.32 grams and 37.66 ± 1.37 weeks, respectively. Multivariable logistic regression demonstrated that birth weight ≥ 2500 grams decreased risk ofrebound neonatal jaundice requiring phototherapy (OR 0.29, 95%CI: 0.12-0.72, p-value 0.005) while a weight loss of ≥ 5% ( the difference between birth weight and weight at the last day of the first phototherapy ) increases the risk
(OR 1.98, 95% CI:1.10-3.57, p-value 0.023)
Conclusion : The prevalence of readmission for phototherapy due to rebound jaundice in Chaiyaphum Hospital was estimated at 1 out of 6 jaundice infants with GA ≥ 35 weeks. Low birth weight and losing weight ≥ 5% from birth weight on hospital discharge day were the significant risk factors of readmission for phototherapy.

Downloads

Download data is not yet available.

References

Kevin Ives N. Neonatal jaundice In: Janet M. Rennie editer. Rennie&Roberton’s Textbook o f Neonatology. British. ELSEVIER.2012:672-692.

American Academy of Pediatrics, Clinical practice guideline subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in newborn infant 35 or more week of gestation. Pediatrics 2004;114:297-361.

Management of hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics . 2004; July: 114(2)297-316. www.aappublications.org/ news สืบค้นเมื่อ 3 ธันวาคม 2020.

Maisels M.J, Kring E.A. Length of stay jaundice and hospital readmission.Pediatrics.

;101: 995-8.

Lee K, Perlaman M, Ballantyne M, et al. Association between duration of neonatal hospital stay and readmission rate. J Pediatr. 1995; 127: 758-66.

Soskolne E.L , Schumacher R, Fyock C, et al. The effect of early discharge and other factors on readmission rates of newborns.

Arch Pediatric Adolesc Med. 1996;150:373-9.

Grupp-Phelan J, Taylor J, Liu L, Davis R. Early newborn hospital discharge and readmission for mild and severe jaundice. Arch Pediatr Adolesc Med. 1999;153:1283-8.

Bansal A, Jain S, Parmar Veena R ,et al .Bilirubin Rebound after intensive phototherapy for neonatal jaundice.Indian pediatrics. 2010 July; 47(17) :607-609.

Soni R, Kaushik S, Kaushik R, et al. Post phototherapy bilirubin rebound: incidence and risk factors. Int J Res in Med Sci.2017 Sep;5(9):4112-4116.

Kaplan M, Kaplan E, Hammerman C, et al. Post-phototherapy neonatal bilirubin rebound: potential cause of significant hyperbilirubinaemia. Arch Dis Child. 2006;91:31-34.

AI-Maaroof Z, Abbas W, Shatti A. Rebound increase in Bilirubin level with itsrisk factors after treatment by Intensive phototherapy for

neonatal Hyperbilirubinemia. Indian Journal of Public Health Research & development, 2019 February; 10(02): 646-652.

Chang P, Kuzniewicz M, McCulloch C, et al. A clinical prediction rule for rebound hyperbilirubinemia following inpatient phototherapy. Pediatrics. 2017 March;139(3):e20162896. เข้าถึง https://pediatrics.aappublications.org/content/139/3/e20162896

โครานาม. commonproblemsintheNursery. In สันติ ปุณณะหิตานนท์ บรรณาธิการ. Practical Points and updates in neonatal care. 2562:73-83.

กาญจนพัฒนกุล ว. ภาวะเหลืองในทารกแรกเกิด(neonatal jaundice).ใน: วิบูลย์ กาญจนพัฒนกุล, ศรีศุภลักษณ์ สิงคาลวณิช, และคณะ บรรณาธิการ. ตำ รากุมารเวชศาสตร์ มหาวิทยาลัยรังสิต. 2558:377-385.

Valinjkar S, Sutay N, Sharma B. Rebound Hyperbilirubinemia in neonates after phototherapy and factor affecting It. JMSCR 2017 March; 05(03):19003-19014.

สุุขยานุดิษฐ น. ความชุุกและปัจจัยเสี่่ยงของการรักษาด้้วยการส่่องไฟซ้ำในทารกแรกเกิดที่มีภาวะตัวเหลืองในโรงพยาบาลท่าตููม จังหวัดสุรินทร์.สำำนักงานป้องกันควบคุมโรคที่ 6 จังหวัดขอนแก่น ตุลาคม2555-มีนาคม2556;20(1):19-30

BlumovichA, Mangel L,Yochpaz S, Mandel D, Marom R. Risk factors for readmission for phototherapy due to jaundice in healthy

newborns: a retrospective, observational study. BMC Pediatr. 2020, 26;20:248

ผาตากแดด ส. ปัจจัยเสี่ยงของ การกลับมารักษาซ้ำในทารกแรกเกิดตัวเหลือง ในโรงพยาบาลสุุวรรณภููมิ จังหวัดร้อยเอ็ด . ร้อยเอ็ดเวชสาร.2562;6(1):1-8.

Elhawary I, Ghany A, Aboelhamed W, et al. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia. World Journal of pediatrics.2018; 14:350-356.

Burgos AE, Schmitt SK, Stevenson DK, Phibbs CS. Readdmission for neonatal jaundice in california, 1991-2000: trends and

implications. Pediatrics. 2008 Apr; 121(4):e864-9

Downloads

Published

2023-03-31

How to Cite

Watthanaphanalai, S. (2023). Prevalence and Risk factors of Hospital Readmission for Phototherapy due to Rebound Neonatal Jaundice in Chaiyaphum hospital. Thai Journal of Pediatrics, 62(1), 9–16. retrieved from https://he04.tci-thaijo.org/index.php/TJP/article/view/1050

Issue

Section

Original Articles